Veterinary API Market

Phibro Animal Health Corporation (US) and Fabbrica Italiana Sintetici S.p.A. (Italy) are Leading Players in the Veterinary API Market

The Global Veterinary API Market is projected to reach USD 11.9 billion by 2028 from USD 8.5 billion in 2023, at a CAGR of 6.9% the forecast period. There are several factors which drive the Veterinary API Market like rising incidence of transboundary & zoonotic diseases, increasing animal population and pet ownership, and increasing disease control & disease prevention measures. The veterinary API industry is anticipated to develop because of the rising demand for veterinary medicines and other animal health products.

The market for Veterinary API Market is dominated by companies like Phibro Animal Health Corporation (US), Fabbrica Italiana Sintetici S.p.A. (Italy), Sequent Scientific Ltd. (India), Excel Industries Ltd. (India), NGL Fine-Chem Ltd. (India), Insud Pharma (Spain), Menadiona Sl (Spain), Rochem International Inc. (US), and Shaanxi Hanjiang Pharmaceutical Group Co. Ltd. (China)

To know about the assumptions considered for the study download the pdf brochure

Phibro Animal Health Corporation (US)

In 2022, Phibro Animal Health Corporation held an approximate major market share in the veterinary API market. It is a leading global animal health and nutrition company that develops, manufactures, and markets a wide range of products and solutions for livestock and poultry. Their product portfolio includes nutritional specialty products, vaccines, antibiotics, medicated feed additives, and other pharmaceuticals. These products are designed to prevent and treat diseases, improve feed efficiency, promote growth, and support optimal animal performance. The company serves a diverse customer base that includes livestock and poultry producers, veterinarians, and feed manufacturers across the globe. Their products are utilized in various sectors, such as poultry, swine, cattle, aquaculture, and companion animals.

Fabbrica Italiana Sintetici S.p.A. (Italy)

Fabbrica Italiana Sintetici S.p.A. (FIS) is an Italian pharmaceutical company with a specialization in the production and development of active pharmaceutical ingredients (APIs) and intermediates. Established in 1950, FIS has grown into a reputable global player in the pharmaceutical industry, known for its quality products and commitment to innovation. FIS operates across multiple therapeutic areas, including cardiovascular, central nervous system, anti-infective, and respiratory. The company's extensive portfolio of APIs encompasses a wide range of chemical classes, allowing them to serve diverse pharmaceutical companies and meet various therapeutic needs. In addition to API production, FIS offers contract manufacturing services, providing custom synthesis and process development solutions to pharmaceutical partners. They collaborate closely with clients to meet their specific requirements and deliver tailored solutions.

Sequent Scientific Ltd. (India)

Sequent Scientific Ltd. is an pharmaceutical company based in India that specializes in the development, manufacturing, and marketing of animal health products and active pharmaceutical ingredients (APIs). The company operates through its two main divisions: Sequent Research, which focuses on the development and manufacturing of APIs, and SeQuent Animal Health, which is responsible for the production and distribution of animal health products. Sequent Scientific's API division is engaged in the development and manufacturing of high-quality APIs for both human and veterinary pharmaceuticals. The company has a strong research and development team that works on process development, optimization, and synthesis of APIs. Their API portfolio covers a broad range of therapeutic areas, including cardiovascular, anti-inflammatory, analgesics, anti-infectives, and central nervous system disorders.

Insud Pharma (Spain)

Insud Pharma is a pharmaceutical company based in Spain. It is part of the Insud Pharma Group, a global healthcare organization with a presence in over 40 countries. Insud Pharma Spain specializes in the research, development, manufacturing, and commercialization of a wide range of pharmaceutical products. The company operates across multiple therapeutic areas, including cardiovascular, central nervous system, respiratory, gastrointestinal, and oncology. Their portfolio comprises prescription medicines, over-the-counter (OTC) products, and generics medicines.

Related Reports:

Veterinary API Market by API Type (Antimicrobials (Fluoroquinolones, Tetracyclines), Vaccines, Hormones, Antimicrobials, Anti-inflammatory, Hormones), Synthesis Type, Route of Administration, and Animal Type - Global Forecast to 2028

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]

Veterinary API Market Size,  Share & Growth Report
Report Code
PH 8696
RI Published ON
6/20/2023
Choose License Type
BUY NOW
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

SEND ME A FREE SAMPLE
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2023 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status